Elixinol Wellness

Elixinol Wellness FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Elixinol Wellness (EXL.AX) as of Oct 17, 2026 is 59.62 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 204.94 % — a change of -70.91% (lower).

FCF Conversion

59.62 %

YoY

-70.91%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Elixinol Wellness is 2025 59.62 % . FCF Conversion Rate (FCF/EBITDA) of Elixinol Wellness was 2024 204.94 % . It decreases by -70.91% lower compared to the previous year.

The Elixinol Wellness FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
1,132.67 AUD
Jan 1, 2019
77.16 AUD
Jan 1, 2020
21.96 AUD
Jan 1, 2021
84.36 AUD
Jan 1, 2022
77.23 AUD
Jan 1, 2023
36.97 AUD
Jan 1, 2024
204.94 AUD
Jan 1, 2025
59.62 AUD
The Elixinol Wellness FCF Conversion history
YEARFCF ConversionYoY
59.62 %-70.91%
204.94 %+454.40%
36.97 %-52.14%
77.23 %-8.46%
84.36 %+284.18%
21.96 %-71.54%
77.16 %-93.19%
1,132.67 %+4,566.69%
24.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Elixinol Wellness Stock analysis

What does Elixinol Wellness do? Elixinol Wellness Ltd, trading under the ticker symbol EXL.AX and identified by the ISIN AU000000EXL4, is a Sydney-based entity operating within the Consumer Staples sector, specifically in the consumer products industry. The company officially entered the public markets through an initial public offering on January 8, 2018. Its primary business activity involves the sale of nutraceutical and related hemp products, positioning itself as a significant player in the global hemp-derived wellness market. The corporate headquarters are located in Sydney, New South Wales, serving as the central hub for its international operations and strategic direction. The firm’s commercial activities are broadly categorized into marketing and selling hemp-derived nutraceutical, cosmetic, and food products under two core brands: Elixinol and Hemp Foods Australia. The company’s operational footprint is extensive, covering various key markets across the globe. In the Americas, the company operates through a presence in Colorado, United States, where it markets and sells Elixinol branded hemp and other plant-derived nutraceutical and skincare products. This North American segment represents a crucial part of its consumer-facing strategy. In Australia, the company’s operations include Hemp Foods Australia, which functions as a wholesaler, retailer, manufacturer, and exporter of both bulk and branded raw materials as well as finished products. This dual-brand approach allows the company to cater to different segments of the market, from raw material supply to direct consumer goods. Internationally, the Elixinol brand is distributed through a network of distribution and trademark licensing agreements. This model is utilized in markets including the United Kingdom, South Africa, Japan, Brazil, and Mexico, with approvals pending for Malaysia. These licensing and distribution arrangements enable the company to expand its reach without necessarily establishing direct operational subsidiaries in every jurisdiction. Additionally, the company serves the Rest of World market by distributing Elixinol branded hemp-derived products through various distributors. This multi-faceted approach to global distribution allows Elixinol Wellness Ltd to leverage local partnerships while maintaining brand consistency. The company’s website, https://www.elixinolwellness.com/site/content/, serves as a central point for information regarding its products and corporate updates. By combining direct operations in key markets with licensing and distribution agreements elsewhere, Elixinol Wellness Ltd aims to capitalize on the growing demand for hemp-based wellness solutions across diverse geographical regions. Elixinol Wellness is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Elixinol Wellness stock

FCF Conversion Rate (FCF/EBITDA) of Elixinol Wellness is 59.62 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Elixinol Wellness changed from 204.94 % to 59.62 %, representing a -70.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Elixinol Wellness since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Elixinol Wellness with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Elixinol Wellness

All Key Metrics — Elixinol Wellness